Cheap Stock to Buy #7 – Optimer Pharmaceutical (OPTR)
Hilary Kramer, Editor, Breakout Stocks Under $5
Optimer Pharmaceutical (NASDAQ: OPTR) is a biopharmaceutical company that focuses on anti-infective products, including ones that treat gastrointestinal infections and related diseases. The stock dipped last month, and looks to have found support just under $12.
A lack of news from the company hasn’t given new investors a reason to get in, but I think that will change. Its new anti-infective drug, Dificid, was approved at the end of May, and Optimer has good label and marketing agreements that should lead to a successful launch. Earnings will be released in early August, and I expect an update on Dificid will get investors interested. Use this pullback as an opportunity to buy this cheap stock.












Comments are currently unavailable. Please check back soon.